Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 12.35B | 11.72B | 11.82B | 12.69B | 11.61B | 12.02B |
Gross Profit | 12.35B | 12.22B | 13.51B | 12.69B | 11.54B | 12.14B |
EBITDA | 2.00B | 2.60B | 2.31B | 2.40B | 2.30B | 1.32B |
Net Income | 1.42B | 1.33B | 1.25B | 1.28B | 1.20B | 990.00M |
Balance Sheet | ||||||
Total Assets | 863.68B | 851.06B | 876.89B | 895.00B | 970.15B | 963.50B |
Cash, Cash Equivalents and Short-Term Investments | 0.00 | 35.32B | 72.28B | 72.49B | 135.22B | 166.10B |
Total Debt | 200.00M | 4.50B | 40.22B | 50.65B | 114.29B | 105.34B |
Total Liabilities | 830.42B | 818.35B | 838.38B | 858.23B | 930.51B | 922.75B |
Stockholders Equity | 32.38B | 31.84B | 37.64B | 35.91B | 38.77B | 39.91B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 5.38B | -10.18B | -93.42B | -34.14B | 113.18B |
Operating Cash Flow | 0.00 | 5.57B | -9.11B | -92.83B | -33.87B | 113.44B |
Investing Cash Flow | 0.00 | -18.74B | 9.42B | 31.35B | 4.58B | 2.13B |
Financing Cash Flow | 0.00 | -23.73B | -6.89B | -384.00M | -378.00M | -378.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | ¥12.65B | 9.79 | ― | 3.66% | 9.46% | 9.41% | |
73 Outperform | ¥10.59B | 6.03 | ― | 1.26% | 2.20% | ― | |
72 Outperform | ¥12.30B | 10.64 | ― | 3.86% | 7.67% | -26.27% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
61 Neutral | ¥9.06B | 8.65 | ― | 3.00% | -9.75% | 81.65% | |
60 Neutral | ¥9.61B | 6.78 | ― | 4.17% | 2.44% | 10.20% | |
46 Neutral | ¥7.85B | ― | ― | 2.16% | 2.60% | -246.98% |